Latest News
Building an Emergency Fund on a Modest Income
Unexpected expenses do not care how tight your budget is. A flat tire, a lost shift at work, a sick pet, a higher heating bill in winter — any of these can throw off your month if every dollar already has a job. An emergency fund is simply a small pile of money that keeps [...]
Via Visibility · December 23, 2025
Via MarketBeat · December 24, 2025
Bloom Energy stock soared on AI's power rush in 2025. Can the company continue to beat the market in 2026?
Via The Motley Fool · December 24, 2025
Investors in the nuclear energy stock have made a lot of money in one year. Can their winning streak continue?
Via The Motley Fool · December 24, 2025
Rivian's stock has soared over the last four weeks, but its true test will be the release of its upcoming SUV.
Via The Motley Fool · December 24, 2025
Planning ahead for your credit cards can spare your loved ones stress. Here's what really happens to your accounts after you pass away.
Via The Motley Fool · December 24, 2025
This ETF invests in stocks with proven wealth-creating capabilities.
Via The Motley Fool · December 24, 2025
The AI data center operator's stock has been on fire in 2025, but a few concerns could weigh on it next year.
Via The Motley Fool · December 24, 2025
This alternative energy company has underperformed for several years.
Via The Motley Fool · December 24, 2025
Markets broke higher with steady buying led by the S&P 500, improving breadth, renewed strength in megacap tech, and concurrent gains in gold and silver, signaling favorable risk-reward into year-end.
Via Talk Markets · December 24, 2025
The company has entered into definitive agreements to issue roughly 2.02 million shares of its common stock in a private placement deal.
Via Stocktwits · December 24, 2025
The Social Security program experiences at least a few changes each year.
Via The Motley Fool · December 24, 2025
According to data released by the U.S. Department of Labor on Wednesday, jobless claims fell by 10,000 to 214,000 in the week ended December 20.
Via Stocktwits · December 24, 2025
Via Benzinga · December 24, 2025
Via MarketBeat · December 24, 2025
Hims & Hers has drawn scrutiny for selling compounded GLP-1 treatments – lower-cost, unapproved alternatives to blockbuster weight-loss drugs made by Eli Lilly and Novo Nordisk.
Via Stocktwits · December 24, 2025
Via Benzinga · December 24, 2025
US GDP utterly crushed it in Q3, and that was following Q2 when output supposedly was well more than expected, so two quarters in a row of booming numbers.
Via Talk Markets · December 24, 2025
REITs are out of favor, offering dividend investors a chance to buy industry leaders while they have attractive yields.
Via The Motley Fool · December 24, 2025
This basket of 64 medical device stocks could raise its dividend for decades.
Via The Motley Fool · December 24, 2025
FDA issued a Class I recall for Medtronic's Left Heart Vent Catheters due to safety concerns. 3 injuries reported.
Via Benzinga · December 24, 2025